EYES: Second Sight Medical Products, Inc. - Summary | Jitta

Second Sight Medical Products, Inc.

NASDAQ:EYES

Notice
Stock data is unavailable or the company’s delisted.
Price
$2.28
Loss Chance
58.4%
0.80JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (23)
Recent Business Performance (17)
Financial Strength (38)
Return to Shareholders (0)
Competitive Advantage (12)
Jitta Signs
Operating MarginInconsistent
Recent Business PerformanceEarning decline 34.64% in the last quarter (yoy)
New Share IssuedMore than 50% in 5 years
CapExVery High
Key Stats
Jitta Score
Jitta Line
0.80
100.00%
2.11
299.84%
2.11
299.84%
4.41
53.66%
3.32
38.04%
2.67
16.43%
COMPANY DESCRIPTION
As of August 30, 2022, Second Sight Medical Products, Inc. was acquired by Nano Precision Medical, Inc., in a reverse merger transaction. Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. The company was founded in 1998 and is headquartered in Sylmar, California.